What researchers published on Köpenysejtes limfóma
2638 papers, newest first.
Showing 40 of 2638
EsetismertetésCase Report: Cytomegalovirus retinitis in an HIV-negative patient with splenic mantle cell lymphoma treated with bendamustine-rituximab.Frontiers in immunology
Clinical, histopathological and molecular characterization of mantle cell lymphoma with MALToma-like presentation.Histopathology
Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.American journal of hematology
The Histone Lactylation of KREMEN2 Inhibits Ferroptosis Through the JAK2/STAT3/GPX4 Axis and Promotes the Progression of Mantle Cell Lymphoma.Hematological oncology
Esetismertetés[Composite follicular lymphoma and mantle cell lymphoma: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology
EsetismertetésIncidental CD5 Negative Mantle Cell Lymphoma in a Gastrointestinal Stromal Tumor: An Unusual Case Suspicious for a Non-Nodal Variant.International journal of laboratory hematology
Socioeconomic deprivation does not affect survival outcomes in patients with mantle cell lymphoma: evidence from a German nationwide study.Blood cancer journal
Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphoma.Leukemia & lymphoma
Treatment patterns and healthcare utilization for patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) in the Veterans Health Administration (MCLOVA) who were prescribed their first Bruton Tyrosine Kinase inhibitor (BTKi): A national retrospective cohort study.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma.Blood neoplasia
Real-World Treatment Patterns, Burden of Illness, and Survival of Autologous Stem Cell Transplant-Ineligible Patients With Mantle Cell Lymphoma in Ontario, Canada.EJHaem
Spurious CD34 expression in mantle cell lymphoma due to non-specific binding to PerCP-Cy5.5: A diagnostic pitfall.Cytometry. Part B, Clinical cytometry
Improving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras.Blood cancer journal
EsetismertetésProgressive Pancytopenia in the Setting of Severe Pneumonia in a Patient With a History of Mantle Cell Lymphoma: A Case Report.Cureus
CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital.Acta clinica Belgica
Early Integration of CAR T-Cell Therapy in Mantle Cell Lymphoma: Expert Opinion in the Era of BTK Inhibitors.Hematological oncology
EsetismertetésAcute abdominal presentation of mantle cell lymphoma mimicking acute appendicitis: a case report.Journal of surgical case reports
ROR1 upregulation after CD19-CAR T-cell relapse in mantle cell lymphoma identifies a targetable vulnerability for ROR1-directed bispecific modalities.Leukemia
EsetismertetésCase Report: Ischemic central retinal vein occlusion in a patient with relapsed mantle cell lymphoma as a manifestation of suspected cancer-associated hypercoagulability.Frontiers in medicine
MetaanalízisClinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.Journal of managed care & specialty pharmacy
CD70-driven immunosuppression in mantle cell lymphoma identifies a vulnerability to CD70-Directed bispecific antibody modalities.Cancer letters
Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis.Blood neoplasia
A prospective, multi-center, phase IV clinical study to assess the safety and clinical outcome of acalabrutinib in Indian adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed/refractory mantle cell lymphoma.Frontiers in oncology
Rituximab maintenance following frontline bendamustine-rituximab in mantle cell lymphoma: a systematic review and meta-analysis.Haematologica
EsetismertetésClassic mantle cell lymphoma with aberrant immunohistochemical expression of Fc receptor-like 4/immunoglobulin superfamily receptor translocation-associated 1.BMJ case reports
A Case of Leukemic Phase of Mantle Cell Lymphoma Diagnosed With Scarring Conjunctivitis and Bilateral Upper Palpebral Conjunctival Tumor.Cornea
Megfigyeléses vizsgálatContemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort.Hematological oncology
EsetismertetésCoinfection of Pneumocystis jirovecii and Aspergillus fumigatus in the lung: A case report.Medicine
IrányelvB-Cell Lymphomas, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.Journal of the National Comprehensive Cancer Network : JNCCN
EsetismertetésExtensive Neurolymphomatosis as the Sole Site of Relapse in Mantle Cell Lymphoma.Clinical nuclear medicine
Targeting ROR1 with KAN571C disrupts resistance networks in mantle cell lymphoma.Blood neoplasia
Treatment of Mantle Cell Lymphoma in Asia: Updated Consensus from the Asian Lymphoma Study Group.Cancer research and treatment
Acalabrutinib Added To Rituximab, Bendamustine (ABR) in Newly Diagnosed High Risk Mantle Cell Lymphoma: an Early Indian Experience.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Áttekintés[Advances in single cell omics applications in mantle cell lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[CD20-negative/CD10-positive mantle cell lymphoma (blastic variant): a case report].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
EsetismertetésCase Report: Occult mantle cell lymphoma in a synchronous rectal collision tumor with adenocarcinoma: retrospective reclassification and multispecimen molecular profiling.Frontiers in oncology
MetaanalízisComparative Efficacy of BTK Inhibitors in Treatment-Naïve and Relapsed/Refractory Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis.Journal of cellular and molecular medicine
ÁttekintésHigh time for risk-adapted treatment in mantle cell lymphoma.The Lancet. Haematology
FDA grants accelerated approval to BCL-2 inhibitor sonrotoclax for mantle cell lymphoma.Cancer
Vizsgálati eredményCD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.The Lancet. Haematology